echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Br J Cancer: Screening for new biomarkers associated with prostate cancer and death based on the UK Bios sample bank.

    Br J Cancer: Screening for new biomarkers associated with prostate cancer and death based on the UK Bios sample bank.

    • Last Update: 2020-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Prostate cancer, the second largest cancer among men in the world after lung cancer, is one of the leading causes of cancer death.
    previous studies have shown that higher concentrations of IGF-1 (insulin-like growth factor-I) in the body correspond to a higher risk of prostate cancer, while obesity is associated with a higher risk of invasive disease.
    , low levels of testosterone can reduce the risk of prostate cancer.
    the pathogenesis of prostate cancer is not yet known, it is particularly important to identify new risk factors for the disease.
    the study aims to identify new factors affecting prostate cancer morbidity and mortality in the UK Biobank.
    researchers collected as many as 211,754 male baseline blood samples and subseeds from five years later, and measured a range of biomarkers associated with cardiovascular, bone, joint, diabetes, kidney and liver.
    follow-up of participants through a health management data set to identify cases of prostate cancer.
    -related markers detected a higher risk than the researchers found that after an average follow-up time of 6.9 years, a total of 5,763 cases of prostate cancer and 331 deaths from prostate cancer were identified.
    studies have shown that the occurrence of prostate cancer is positively related to the concentration of vitamin D, urea and phosphate in the body's circulation, and negatively related to glucose, total protein, and tyrosine transaminase.
    phosphate and cystatin-C (cysteine protease inhibitor-C) were the only positive and reverse biomarkers, respectively, and were associated with the risk of onset in follow-up (excluding the previous 4 years).
    there is currently no evidence of factors associated with prostate cancer deaths.
    , the study found several new biomarkers associated with the incidence of prostate cancer and provided a basis for future research into the disease.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.